Latest News about VIR
Recent news which mentions VIR
2 Stocks That Could Turn $100 Into $1,000 by 2028
January 22, 2023
From Motley Fool
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
2 Fast-Growing Healthcare Stocks to Buy and Hold
December 02, 2022
From Motley Fool
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
December 02, 2022
From Benzinga
From Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
November 18, 2022
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
FDA Moves Step Closer For Opioid Overdose Medication Access, Says Certain Naloxone Products Can Potentially Be Used In OTC Setting
November 15, 2022
From Benzinga
Data From Multiple Ongoing Trials Of Vir Biotech's HBV Therapies Show Promising Action
November 07, 2022
Tickers
VIR
From Benzinga
From Benzinga
Why Vir Biotechnology Jumped Nearly 19% Today
November 04, 2022
From Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
November 04, 2022
From Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
From Benzinga
What 5 Analyst Ratings Have To Say About Vir Biotechnology
November 04, 2022
Tickers
VIR
From Benzinga
Block, MasTec, Universal Display And Some Other Big Stocks Moving Higher On Friday
November 04, 2022
From Benzinga
Earnings Scheduled For November 3, 2022
November 03, 2022
From Benzinga
From Benzinga
This Addiction Drug Shows Some Potential Against Long COVID Symptoms
October 19, 2022
From Benzinga
Vir Biotech Secures US Government Contract For Influenza & Other Infectious Disease Candidates
October 04, 2022
Tickers
VIR
From Benzinga
3 Biotech Stocks to Buy Now for Extraordinary Gains
September 20, 2022
From InvestorPlace
From Benzinga
This Hepatitis Stock Has 'Multiple Paths To Value Creation,' Expects To Double, Bullish Analyst Predicts
September 14, 2022
Tickers
VIR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2022
September 09, 2022
From Benzinga
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox
September 02, 2022
From Benzinga
Landmark Drug Pricing Reform Bill Passes Congress House
August 15, 2022
From Benzinga
From Benzinga
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 10, 2022
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.